Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
寻求晚期心力衰竭 (SOCIAL HF) 治疗试验分配的客观性
基本信息
- 批准号:10440891
- 负责人:
- 金额:$ 74.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdoptionAffectAttitudeChronic DiseaseClinical TrialsCluster randomized trialColorComplexDataDecision MakingEffectivenessEthnic OriginEvaluationGenderGoalsGuidelinesHeartHeart TransplantationHeart failureIndividualInfrastructureInstitute of Medicine (U.S.)KnowledgeLeadLearningLifeMaintenanceMeasuresMethodsModelingMotivationOrganOutcomePatientsPersonsPhenotypePopulationProcessProtocols documentationRaceRandomizedReach Effectiveness Adoption Implementation and MaintenanceReportingResearchResourcesSavingsSiteSocial supportStandardizationSurveysTestingTherapy trialTrainingTreatment FailureVariantVotingWomanbehavior changebehavior change wheeldesigneffectiveness evaluationeffectiveness implementation studyeffectiveness implementation trialeffectiveness testingevidence basehealth equityimplantationimplementation evaluationimplementation outcomesimplementation scienceimplementation strategyimplicit biasimprovedmedication compliancemeetingsmultidisciplinarypeople of colorprogramsracial and ethnicself reported behaviortheoriestrial designventricular assist device
项目摘要
ABSTRACT
Standardized protocols can reduce the impact of implicit bias but are underused. Since the Institute of
Medicine’s report, “Unequal Treatment”, multiple studies have confirmed that standardization of decision-
making processes reduces bias, but bias in the allocation of advanced therapies has not been addressed.
Using an evidence-based framework for behavior change [Capability, Opportunity, and Motivation for Behavior
Change/Behavior Change Wheel (COM-B/BCW)], we developed a standardized protocol strategy, Seeking
Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF), that addresses significant barriers to equity in
advanced therapies: 1) bias, 2) subjectivity in evaluation of social support and adherence, and 3) poor group
dynamics. Thus, SOCIAL HF includes: 1) evidence-based bias training tailored for HF, 2) restriction to
objective evaluations of social support and adherence, and 3) environmental restructuring and modeling of
meeting settings to include anonymous electronic voting and equitable seating arrangement. In complex
decision-making that includes individuals and groups, our standardized protocol strategy, SOCIAL HF, has the
greatest likelihood of achieving health equity in advanced HF. Our goal is to assess real-world effectiveness
(Aim 1) and implementation (Aim 2) of SOCIAL HF for allocation of advanced HF therapies, heart transplant
and ventricular assist device implantation. We will use a cluster randomized design to test the effectiveness of
SOCIAL HF strategy. We will evaluate implementation of SOCIAL HF across study sites using mixed-methods
in order to learn optimal implementation strategies to achieve equity. We will use normalization process theory
to evaluate how SOCIAL HF affects processes and outcomes important to advanced HF centers (e.g.
fidelity/variation). We will use RE-AIM framework (reach, effectiveness, adoption, implementation, and
maintenance) to evaluate factors that promote reach and adoption and resources needed for implementation.
We have the relationships, infrastructure, and expertise to execute this project; our multidisciplinary team
includes experts in HF, evidence-based bias reduction training, clinical trials, mixed-methods, and
implementation science.
摘要
标准化的协议可以减少隐性偏见的影响,但未得到充分利用。自研究所
医学的报告,“不平等的待遇”,多项研究已经证实,标准化的决定-
制定流程减少了偏差,但先进疗法分配中的偏差尚未得到解决。
使用基于证据的行为改变框架[行为的能力、机会和动机
改变/行为改变轮(COM-B/BCW)],我们开发了一种标准化的协议策略,
晚期心力衰竭分配的客观性(社会HF),解决了公平分配的重大障碍,
先进疗法:1)偏倚,2)社会支持和依从性评价的主观性,3)贫困群体
动力学因此,社会HF包括:1)针对HF量身定制的循证偏倚培训,2)限制
社会支持和坚持的客观评价,3)环境重建和建模,
会议设置包括匿名电子投票和公平座位安排。在复杂
决策,包括个人和团体,我们的标准化协议策略,社会HF,具有
最有可能在晚期HF中实现健康公平。我们的目标是评估现实世界的有效性
(Aim 1)和实施(目标2)用于分配高级HF治疗、心脏移植的社会HF
和心室辅助装置植入。我们将采用整群随机设计来测试
社会HF战略。我们将使用混合方法评价各研究中心的社会HF实施情况
以便学习实现公平的最佳执行战略。我们将使用规范化过程理论
评估社会HF如何影响对高级HF中心重要的过程和结果(例如,
保真度/变化)。我们将使用RE-AIM框架(覆盖范围、有效性、采用率、实施和
维护),以评估促进普及和采用的因素以及实施所需的资源。
我们拥有执行该项目的关系、基础设施和专业知识;我们的多学科团队
包括HF专家,循证偏倚减少培训,临床试验,混合方法,
执行科学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Khadijah Breathett其他文献
Khadijah Breathett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Khadijah Breathett', 18)}}的其他基金
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
寻求晚期心力衰竭 (SOCIAL HF) 治疗试验分配的客观性
- 批准号:
10617805 - 财政年份:2022
- 资助金额:
$ 74.57万 - 项目类别:
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
寻求晚期心力衰竭 (SOCIAL HF) 治疗试验分配的客观性
- 批准号:
10474768 - 财政年份:2021
- 资助金额:
$ 74.57万 - 项目类别:
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
寻求晚期心力衰竭 (SOCIAL HF) 治疗试验分配的客观性
- 批准号:
10591649 - 财政年份:2021
- 资助金额:
$ 74.57万 - 项目类别:
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic Minorities
解决少数种族/族裔高级心力衰竭治疗选择中的个体提供者偏见和群体决策
- 批准号:
9755243 - 财政年份:2018
- 资助金额:
$ 74.57万 - 项目类别:
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic Minorities
解决少数种族/族裔高级心力衰竭治疗选择中的个体提供者偏见和群体决策
- 批准号:
10205156 - 财政年份:2018
- 资助金额:
$ 74.57万 - 项目类别:
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic Minorities
解决少数种族/族裔高级心力衰竭治疗选择中的个体提供者偏见和群体决策
- 批准号:
10578988 - 财政年份:2018
- 资助金额:
$ 74.57万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 74.57万 - 项目类别:
Fellowship Programs